We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$74.9B
AUM Growth
+$9.23B
Cap. Flow
+$7.27B
Cap. Flow %
9.7%
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.04B
2
MSFT icon
Microsoft
MSFT
+$830M
3
AMZN icon
Amazon
AMZN
+$550M
4
JNJ icon
Johnson & Johnson
JNJ
+$483M
5
AAPL icon
Apple
AAPL
+$470M

Sector Composition

Rank Sector Weight
1 Technology 18.7%
2 Consumer Discretionary 13.75%
3 Healthcare 12.4%
4 Financials 7.81%
5 Industrials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRC icon
2576
California Resources
CRC
$4.87B
-273,010
Closed -$15M
CRD.B icon
2577
Crawford & Co Class B
CRD.B
$580M
-18,905
Closed -$171K
CRESY
2578
Cresud
CRESY
$758M
-47,961
Closed -$425K
CREVW
2579
CALL
DELISTED
Carbon Revolution PLC Warrant
CREVW
-50,576
Closed -$535K
CRI icon
2580
Carter's
CRI
$1.47B
-3,200
Closed -$271K
CSCO icon
2581
CALL
Cisco
CSCO
$490B
-892,100
Closed -$43.7M
CSCO icon
2582
PUT
Cisco
CSCO
$490B
-1,241,700
Closed -$60.8M
CSGP icon
2583
CoStar Group
CSGP
$12.5B
-13,612
Closed -$1.31M
CTAS icon
2584
Cintas
CTAS
$80.8B
-107,200
Closed -$18.4M
CTKB icon
2585
Cytek Biosciences
CTKB
$569M
-68,591
Closed -$460K
CTMX icon
2586
CytomX Therapeutics
CTMX
$739M
-52,289
Closed -$114K
CTRN icon
2587
Citi Trends
CTRN
$627M
-18,058
Closed -$490K
CUBE icon
2588
CubeSmart
CUBE
$9.21B
-10,800
Closed -$488K
CUK
2589
DELISTED
Carnival PLC
CUK
-46,700
Closed -$688K
CVAC
2590
DELISTED
CureVac
CVAC
-14,610
Closed -$44.3K
CZR icon
2591
Caesars Entertainment
CZR
$6.15B
-507,913
Closed -$22.2M
DAL icon
2592
Delta Air Lines
DAL
$58.9B
-1,868,957
Closed -$89.5M
DDL
2593
Dingdong
DDL
$520M
-149,432
Closed -$182K
DHX icon
2594
DHI Group
DHX
$162M
-50,548
Closed -$129K
DIA icon
2595
CALL
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.3B
-58,700
Closed -$23.2M
DKNG icon
2596
CALL
DraftKings
DKNG
$12.1B
-444,000
Closed -$19.6M
DLHC icon
2597
DLH Holdings
DLHC
$69.9M
-18,630
Closed -$247K
DNA icon
2598
Ginkgo Bioworks
DNA
$501M
-13,612
Closed -$632K
DOCN icon
2599
DigitalOcean
DOCN
$15.2B
-225,561
Closed -$8.61M
DOCS icon
2600
Doximity
DOCS
$4.56B
-84,200
Closed -$2.27M

Similar funds

Marshall Wace's Q2 2024 Portfolio in Review

As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.

  • Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
  • Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
  • Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
  • Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
  • Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.

Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.